Sanofi Sp. z o.o. secures contract for Vaccines - Vaccine against diphtheria, tetanus, pertussis (acellular, composite), poliomyelitis (inactivated) and haemophilus type b (conjugated), adsorbed - inj 0.5 ml, Pentaxim for continuation of initiated vaccination schemes and for the reserve specified in the epidemic regulation Parts 1-3

Poland, Sept. 17 -- Poland based Sanofi Sp. z o.o. has secured contract from Zaklad Zamowien Publicznych przy Ministrze Zdrowia for Vaccines - Vaccine against diphtheria, tetanus, pertussis (acellular, composite), poliomyelitis (inactivated) and haemophilus type b (conjugated), adsorbed - inj 0.5 ml, Pentaxim for continuation of initiated vaccination schemes and for the reserve specified in the epidemic regulation Parts 1-3 . The value of the contract is worth 550000 PLN .

Published by HT Digital Content Services with permission from Pivotal Sources....